Shoulder Innovations, Inc.
NYSE:SIMedical - Specialties
-$0.13 today
- Market cap
- $432.04M
- Beta
- -1.07
- P/E (TTM)
- -8.4
- EPS (TTM)
- -$2.13
Volume 0.09M
Average 0.10M
SI Total Current Assets
All assets expected to be converted to cash or used up within one year.
Shoulder Innovations, Inc.NYSE: SI
Total Current Assets · Q1 FY2026 · quarter ended Mar 2026
Total current assets rises 193.8% from a year ago
Total current assets stood at $145.78M at the end of Q1 FY2026, up 193.8% from a year earlier and down 7.2% from the prior quarter.
Context
- Total current assets amounted to 90.9% of total assets at the end of Q1 FY2026, up 4.7 pp from a year earlier.
- Total current assets increased in 1 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
What to watch
Whether total current assets keeps rising in the next quarterly balance sheet after a +193.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 157.17M USD
- Year-over-year change
- +347.4%
- 2-year CAGR
- +81.2%
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 157.17M | +347.4% |
| FY2024 | 2024-12-31 | 35.13M | -26.6% |
| FY2023 | 2023-12-31 | 47.85M | — |
Total Current Assets vs competitors
How SI compares with its peers on the latest reported figures
- SI's Mar 2026 total current assets of $145.78M is the 5th highest of the 11 companies compared; the peer median is $120.71M.
- Its year-over-year change of +193.8% is the 2nd highest of 11, against a peer median of -16.3%.
- Total current assets amounts to 90.9% of total assets for SI, versus a peer median of 65.6%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $236.71M | -17.4% | -12.4% | 94.9% | |
| Mar 2026 | $232.61M | +143.5% | +37.9% | 98.8% | |
| Mar 2026 | $190.67M | -5.0% | -13.3% | 66.7% | |
| Mar 2026 | $178.41M | -26.5% | -13.1% | 56.7% | |
| Mar 2026 | $145.78M | +193.8% | — | 90.9% | |
EPRXEupraxia Pharmaceuticals Inc. | Mar 2026 | $142.59M | +398.5% | +50.1% | 97.8% |
| Mar 2026 | $98.83M | -30.2% | -17.3% | 55.6% | |
| Mar 2026 | $93.58M | -39.5% | +89.3% | 94.9% | |
| Dec 2025 | $66.79M | -15.1% | -6.8% | 41.2% | |
| Jun 2026 | $43.03M | -20.0% | +22.4% | 32.6% | |
| Mar 2026 | $23.96M | +27.2% | +54.9% | 64.6% | |
| Peer median (excluding SI) | $120.71M | -16.3% | +7.8% | 65.6% | |
Competitors are the stored peer set for SI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Shoulder Innovations, Inc.
NYSE:SI
Intrinsic Alpha fair value
Locked
Current Price
$20.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.